M14-431 A Multicenter Randomized Double-Blind Placebo-Controlled Induction Study of the Efficacy and Safety of Upadacitinib (ABT 494) in Subject's with Moderately to Severely Active Crohn's Disease who have Inadequately Responded to or are Intolerant t
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
